Meyka Pro banner
Bausch + Lomb Corporation

Bausch + Lomb Corporation (BLCO) Stock Overview

Explore Bausch + Lomb Corporation’s financial performance, market position, analyst ratings, and future outlook.

BLCO●NYSE
HealthcareMedical - Instruments & Supplies
$21.14
$0.18(0.84%)
U.S. Market opens in 14h 34m

Bausch + Lomb Corporation (BLCO)

Meyka AI Score

Z

Key Financials

Market Cap7.6B
P/E Ratio-68.36
EPS (TTM)$0.65
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$21.23
3 Months$18.32
1 Year Target$16.68

BLCO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Bausch + Lomb Corporation (NYSE: BLCO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bausch + Lomb Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BLCO on the NYSE shows an RSI of 71.89, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $16.68 for the NYSE listing.

Key metrics behind Bausch + Lomb Corporation's NYSE-traded stock include a P/E ratio of -68.36 and a market capitalization of 7.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BLCO on the NYSE.

Price Performance (NYSE: BLCO)

1-Day Change
-0.82%
5-Day Change
7.44%
1-Month Change
31.58%
3-Month Change
26.16%
6-Month Change
31.91%
Year-to-Date (YTD) Change
23.80%
1-Year Change
27.38%
3-Year Change
33.49%
5-Year Change
5.72%
All-Time (Max) Change
5.72%

Contact Information

905 695 7700
520 Applewood Crescent, Vaughan, ON, L4K 4B4

Company Facts

130,000 Employees
IPO DateMay 6, 2022
CountryCA
Actively Trading

Frequently Asked Questions